(H) Hyatt Hotels - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US4485791028
Stock: Hotels, Resorts, Rentals, Loyalty
Total Rating 44
Risk 53
Buy Signal -0.16
| Risk 5d forecast | |
|---|---|
| Volatility | 44.7% |
| Relative Tail Risk | -7.40% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.53 |
| Alpha | -3.33 |
| Character TTM | |
|---|---|
| Beta | 1.059 |
| Beta Downside | 1.380 |
| Drawdowns 3y | |
|---|---|
| Max DD | 37.28% |
| CAGR/Max DD | 0.30 |
EPS (Earnings per Share)
Revenue
Description: H Hyatt Hotels March 04, 2026
Hyatt Hotels Corporation (H) operates as a global hospitality company. Its business model includes managing, franchising, owning, and leasing properties.
The companys portfolio spans full-service hotels, resorts, and select-service hotels, alongside timeshare and residential units. Hyatt utilizes a brand-centric strategy, operating numerous brands from luxury (e.g., Park Hyatt) to select service (e.g., Hyatt Place). The hospitality sector is characterized by diverse property types and brand differentiation.
Hyatt also offers a loyalty program, World of Hyatt, and a short-term vacation rental platform, Homes & Hideaways. These initiatives aim to enhance customer retention and expand market reach. Further research into Hyatts financial health and market position can be found on ValueRay.
The company serves a broad customer base, including corporate clients, associations, and individual consumers, reflecting the diverse demand drivers within the hotel industry.
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income: -52.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -2.72 > 1.0 |
| NWC/Revenue: 43.94% < 20% (prev -16.41%; Δ 60.35% < -1%) |
| CFO/TA 0.02 > 3% & CFO 329.0m > Net Income -52.0m |
| Net Debt (4.01b) to EBITDA (740.0m): 5.42 < 3 |
| Current Ratio: 58.02 > 1.5 & < 3 |
| Outstanding Shares: last quarter (95.0m) vs 12m ago -1.25% < -2% |
| Gross Margin: 23.83% > 18% (prev 0.43%; Δ 2340 % > 0.5%) |
| Asset Turnover: 38.90% > 50% (prev 24.74%; Δ 14.16% > 0%) |
| Interest Coverage Ratio: 1.28 > 6 (EBITDA TTM 740.0m / Interest Expense TTM 317.0m) |
Altman Z'' 2.44
| A: 0.17 (Total Current Assets 2.38b - Total Current Liabilities 41.0m) / Total Assets 14.04b |
| B: 0.25 (Retained Earnings 3.48b / Total Assets 14.04b) |
| C: 0.03 (EBIT TTM 407.0m / Avg Total Assets 13.68b) |
| D: 0.32 (Book Value of Equity 3.35b / Total Liabilities 10.38b) |
| Altman-Z'' Score: 2.44 = A |
Beneish M -1.86
| DSRI: 0.86 (Receivables 1.56b/1.12b, Revenue 5.32b/3.30b) |
| GMI: 1.78 (GM 23.83% / 42.54%) |
| AQI: 1.25 (AQ_t 0.81 / AQ_t-1 0.64) |
| SGI: 1.61 (Revenue 5.32b / 3.30b) |
| TATA: -0.03 (NI -52.0m - CFO 329.0m) / TA 14.04b) |
| Beneish M-Score: -1.86 (Cap -4..+1) = B |
What is the price of H shares?
As of March 05, 2026, the stock is trading at USD 162.00 with a total of 705,333 shares traded.
Over the past week, the price has changed by -3.54%, over one month by +0.62%, over three months by +3.50% and over the past year by +18.51%.
Over the past week, the price has changed by -3.54%, over one month by +0.62%, over three months by +3.50% and over the past year by +18.51%.
Is H a buy, sell or hold?
Hyatt Hotels has received a consensus analysts rating of 3.64.
Therefor, it is recommend to hold H.
- StrongBuy: 7
- Buy: 1
- Hold: 13
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the H price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 182.5 | 12.7% |
| Analysts Target Price | 182.5 | 12.7% |
H Fundamental Data Overview March 01, 2026
P/E Forward = 34.6021
P/S = 4.3942
P/B = 4.8512
P/EG = 0.7934
Revenue TTM = 5.32b USD
EBIT TTM = 407.0m USD
EBITDA TTM = 740.0m USD
Long Term Debt = 4.27b USD (from longTermDebt, last quarter)
Short Term Debt = 41.0m USD (from shortTermDebt, last quarter)
Debt = 4.80b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.01b USD (from netDebt column, last quarter)
Enterprise Value = 19.27b USD (15.26b + Debt 4.80b - CCE 787.0m)
Interest Coverage Ratio = 1.28 (Ebit TTM 407.0m / Interest Expense TTM 317.0m)
EV/FCF = 176.8x (Enterprise Value 19.27b / FCF TTM 109.0m)
FCF Yield = 0.57% (FCF TTM 109.0m / Enterprise Value 19.27b)
FCF Margin = 2.05% (FCF TTM 109.0m / Revenue TTM 5.32b)
Net Margin = -0.98% (Net Income TTM -52.0m / Revenue TTM 5.32b)
Gross Margin = 23.83% ((Revenue TTM 5.32b - Cost of Revenue TTM 4.05b) / Revenue TTM)
Gross Margin QoQ = 11.12% (prev 39.18%)
Tobins Q-Ratio = 1.37 (Enterprise Value 19.27b / Total Assets 14.04b)
Interest Expense / Debt = 1.83% (Interest Expense 88.0m / Debt 4.80b)
Taxrate = 21.0% (US default 21%)
NOPAT = 321.5m (EBIT 407.0m * (1 - 21.00%))
Current Ratio = 58.02 (Total Current Assets 2.38b / Total Current Liabilities 41.0m)
Debt / Equity = 1.44 (Debt 4.80b / totalStockholderEquity, last quarter 3.33b)
Debt / EBITDA = 5.42 (Net Debt 4.01b / EBITDA 740.0m)
Debt / FCF = 36.81 (Net Debt 4.01b / FCF TTM 109.0m)
Total Stockholder Equity = 3.46b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.38% (Net Income -52.0m / Total Assets 14.04b)
RoE = -1.50% (Net Income TTM -52.0m / Total Stockholder Equity 3.46b)
RoCE = 5.26% (EBIT 407.0m / Capital Employed (Equity 3.46b + L.T.Debt 4.27b))
RoIC = 3.73% (NOPAT 321.5m / Invested Capital 8.62b)
WACC = 7.82% (E(15.26b)/V(20.06b) * Re(9.82%) + D(4.80b)/V(20.06b) * Rd(1.83%) * (1-Tc(0.21)))
Discount Rate = 9.82% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -5.72%
[DCF] Terminal Value 78.83% ; FCFF base≈251.8m ; Y1≈252.7m ; Y5≈269.5m
[DCF] Fair Price = 21.75 (EV 4.91b - Net Debt 4.01b = Equity 898.9m / Shares 41.3m; r=7.82% [WACC]; 5y FCF grow -0.14% → 2.90% )
EPS Correlation: 4.72 | EPS CAGR: 138.8% | SUE: 2.43 | # QB: 1
Revenue Correlation: 51.54 | Revenue CAGR: 26.76% | SUE: 0.08 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.96 | Chg7d=+0.011 | Chg30d=-0.104 | Revisions Net=+1 | Analysts=15
EPS current Year (2026-12-31): EPS=3.37 | Chg7d=-0.018 | Chg30d=-0.013 | Revisions Net=+1 | Growth EPS=+53.7% | Growth Revenue=+1.3%
EPS next Year (2027-12-31): EPS=4.43 | Chg7d=-0.037 | Chg30d=+0.067 | Revisions Net=+0 | Growth EPS=+31.7% | Growth Revenue=+6.0%
[Analyst] Revisions Ratio: +0.33 (2 Up / 1 Down within 30d for Next Quarter)
P/S = 4.3942
P/B = 4.8512
P/EG = 0.7934
Revenue TTM = 5.32b USD
EBIT TTM = 407.0m USD
EBITDA TTM = 740.0m USD
Long Term Debt = 4.27b USD (from longTermDebt, last quarter)
Short Term Debt = 41.0m USD (from shortTermDebt, last quarter)
Debt = 4.80b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.01b USD (from netDebt column, last quarter)
Enterprise Value = 19.27b USD (15.26b + Debt 4.80b - CCE 787.0m)
Interest Coverage Ratio = 1.28 (Ebit TTM 407.0m / Interest Expense TTM 317.0m)
EV/FCF = 176.8x (Enterprise Value 19.27b / FCF TTM 109.0m)
FCF Yield = 0.57% (FCF TTM 109.0m / Enterprise Value 19.27b)
FCF Margin = 2.05% (FCF TTM 109.0m / Revenue TTM 5.32b)
Net Margin = -0.98% (Net Income TTM -52.0m / Revenue TTM 5.32b)
Gross Margin = 23.83% ((Revenue TTM 5.32b - Cost of Revenue TTM 4.05b) / Revenue TTM)
Gross Margin QoQ = 11.12% (prev 39.18%)
Tobins Q-Ratio = 1.37 (Enterprise Value 19.27b / Total Assets 14.04b)
Interest Expense / Debt = 1.83% (Interest Expense 88.0m / Debt 4.80b)
Taxrate = 21.0% (US default 21%)
NOPAT = 321.5m (EBIT 407.0m * (1 - 21.00%))
Current Ratio = 58.02 (Total Current Assets 2.38b / Total Current Liabilities 41.0m)
Debt / Equity = 1.44 (Debt 4.80b / totalStockholderEquity, last quarter 3.33b)
Debt / EBITDA = 5.42 (Net Debt 4.01b / EBITDA 740.0m)
Debt / FCF = 36.81 (Net Debt 4.01b / FCF TTM 109.0m)
Total Stockholder Equity = 3.46b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.38% (Net Income -52.0m / Total Assets 14.04b)
RoE = -1.50% (Net Income TTM -52.0m / Total Stockholder Equity 3.46b)
RoCE = 5.26% (EBIT 407.0m / Capital Employed (Equity 3.46b + L.T.Debt 4.27b))
RoIC = 3.73% (NOPAT 321.5m / Invested Capital 8.62b)
WACC = 7.82% (E(15.26b)/V(20.06b) * Re(9.82%) + D(4.80b)/V(20.06b) * Rd(1.83%) * (1-Tc(0.21)))
Discount Rate = 9.82% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -5.72%
[DCF] Terminal Value 78.83% ; FCFF base≈251.8m ; Y1≈252.7m ; Y5≈269.5m
[DCF] Fair Price = 21.75 (EV 4.91b - Net Debt 4.01b = Equity 898.9m / Shares 41.3m; r=7.82% [WACC]; 5y FCF grow -0.14% → 2.90% )
EPS Correlation: 4.72 | EPS CAGR: 138.8% | SUE: 2.43 | # QB: 1
Revenue Correlation: 51.54 | Revenue CAGR: 26.76% | SUE: 0.08 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.96 | Chg7d=+0.011 | Chg30d=-0.104 | Revisions Net=+1 | Analysts=15
EPS current Year (2026-12-31): EPS=3.37 | Chg7d=-0.018 | Chg30d=-0.013 | Revisions Net=+1 | Growth EPS=+53.7% | Growth Revenue=+1.3%
EPS next Year (2027-12-31): EPS=4.43 | Chg7d=-0.037 | Chg30d=+0.067 | Revisions Net=+0 | Growth EPS=+31.7% | Growth Revenue=+6.0%
[Analyst] Revisions Ratio: +0.33 (2 Up / 1 Down within 30d for Next Quarter)